Patents by Inventor Jean-Francois Bach

Jean-Francois Bach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel polypeptides having thymic activity or an antagonistic activity and processes for their synthesis
    Patent number: 4301065
    Abstract: The invention is concerned with novel polypeptides and processes for the synthesis thereof.It is concerned with compounds having the sequenceX-Gln-Gly-Gly-Yin which Y represents -Ser-Asn and X represents Ser-, Lys-Ser-, Ala-Lys-Ser-, Glx-Ala-Lys-Ser-; Glx representing Pyro-Glu or Gln; and when X represents Glx-Ala-Lys-Ser-, Y may in addition represent -Ser; as well as their derivatives comprising one or two modified amino acids, with the exception of the unmodified compound PyroGlu-Ala-Lys-Ser-Gln-Gly-Ser-Asn.These polypeptides are useful as medicines.
    Type: Grant
    Filed: May 24, 1978
    Date of Patent: November 17, 1981
    Assignee: Agence Nationale de Valorisation de la Recherche (ANVAR)
    Inventors: Jean-Francois Bach, Mireille Dardenne, Jean-Marie Pleau, Jean Hamburger, Evanghelos Bricas, Jean Martinez, Didier Blanot, Genevieve Auger
  • Polypeptide possessing thymic activity
    Patent number: 4148886
    Abstract: The novel thymic factor polypeptide hormone, elaborated by the thymus and und in the blood serum, is isolated. The hormone is useful for the treatment of autoimmune diseases and for selectively stimulating T-cell activity in aging subjects.
    Type: Grant
    Filed: April 25, 1978
    Date of Patent: April 10, 1979
    Assignee: Institute National de la Sante & de la Recherche Medicale (INSERM)
    Inventors: Jean-Francois Bach, Jean Hamburger
  • Polypeptide possessing thymic activity
    Patent number: 4133804
    Abstract: The novel thymic factor polypeptide hormone, elaborated by the thymus and und in the blood serum, is isolated. The hormone is useful for the treatment of autoimmune diseases and for selectively stimulating T-cell activity in aging subjects.
    Type: Grant
    Filed: September 22, 1976
    Date of Patent: January 9, 1979
    Assignee: Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Jean-Francois Bach, Jean Hamburger